Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00469482 · ClinicalTrials.gov registry record · NA
The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT00469482 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 28 participants.
The verdict
NCT00469482, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
A combined strategy of Richmond Agitation and Sedation Scale (RASS) clinical targeting plus bispectral index (BIS) guided sedation in mechanically ventilated, critically ill patients will decrease time on mechanical ventilation, decrease the duration of intensive care unit (ICU) delirium and coma, and will improve subacute neurocognitive function when compared to sedation guided by RASS targeting alone.
Interventions
- OTHER Sedation,RASS Targeted plus BIS Monitoring
- OTHER Sedation, RASS Targeted
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2007-06 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00469482
The ClinicalTrials.gov registry entry for NCT00469482 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sedation,RASS Targeted plus BIS Monitoring is the first listed.
NCT00469482 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00469482 about?
NCT00469482 is a clinical study titled "The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status". A combined strategy of Richmond Agitation and Sedation Scale (RASS) clinical targeting plus bispectral index (BIS) guided sedation in mechanically ventilated, critically ill patients will decrease time on mechanical ventilation, decrease the duration of intensive care unit (ICU) delirium and coma, a...
What is the current status of trial NCT00469482?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2007-06. Estimated completion is 2016-09.
What interventions are being tested in trial NCT00469482?
The interventions under investigation include: Sedation,RASS Targeted plus BIS Monitoring (OTHER), Sedation, RASS Targeted (OTHER).
Who is sponsoring clinical trial NCT00469482?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.